0,1,2,3,4
blocking solution (PBS with 10 % FBS and 0.2 % Tween,,final volume of 10 μl. Forty PCR cycles were performed at,,
Table 1 Primers used in the present study,,,,
Gene name and accession,Sequence (5′–3′),UPL sequence (UPL#)a,Amplicon,Alignmentb
"number
in GenBank",,,bp,
MX1,TCCAGCCACCATTCCAAG,TTCTCCTG (2),60,868–885
NM_001144925.2,CAACAAGTTAAATGGTATCACAGAGC,,,927–902
OAS1,GGTGGAGTTCGATGTGCTG,CCAGGGCA (37),64,538–556
XM_006719434.1,AGGTTTATAGCCGCCAGTCA,,,601–582
IFN-β,CTTTGCTATTTTCAGACAAGATTCA,CTGGCTGG (20),69,336–360
NM_002176.2,GCCAGGAGGTTCTCAAGAAT,,,404–389
,,c,,
IFN-λ1,TCCTAGACCAGCCCCTTCA,,73,435–453
NM_172140.1,GTGGGCTGAGGCTGGATA,,,507–490
,,c,,
IFN-λ2,CCTGGTGGACGTCTTGGA,,84,406–423
NM_172138.1,GTGGGCTGAGGCTGGATA,,,489–472
,,c,,
IFN-λ3,AGGGCCAAAGATGCCTTAG,,123,167–185
NM_172139.2,CAGCTCAGCCTCCAAAGC,,,298–281
HPRT1,–,–,127,–
NM_000194.2d,,,,
